https://pharminent.com/eisai-claims-uk-grant-to-expand-manufacturing-site/ 2026-06-15T14:15:47Z Pharminent en Eisai claims UK grant to expand manufacturing site 2026-06-15T12:19:37Z Blog https://pharminent.com/rhythms-obesity-drug-scores-better-than-expected-weight-loss-in-rare-genetic-disease/ 2026-06-15T14:15:23Z Pharminent en Rhythm's obesity drug scores 'better than expected' weight loss in rare genetic disease 2026-06-15T11:24:33Z Blog https://pharminent.com/fda-clears-msds-keytruda-combo-plus-welireg-for-ccrcc-treatment/ 2026-06-15T14:15:00Z Pharminent en FDA clears MSD's Keytruda combo plus Welireg for ccRCC treatment 2026-06-15T08:55:49Z Blog https://pharminent.com/week-in-review/week-in-review-intelligence-brief-june-13-2026/ 2026-06-13T19:03:54Z Pharminent en Week in Review • INTELLIGENCE BRIEF • June 13, 2026 2026-06-13T19:03:51Z Blog